BO

BOLAK CO.,LTD

Manufacturer of specialty ingredients for the food, pharmaceutical, and cosmetic industries.

002760 | KO

Overview

Corporate Details

ISIN(s):
KR7002760007
LEI:
Country:
South Korea
Address:
경기도 화성시 양감면 초록로 720-37, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1959, Bolak Co., Ltd. is a manufacturer of specialty ingredients and raw materials. The company serves the food, pharmaceutical, and cosmetic industries with a diverse product portfolio. Key offerings include food additives such as flavors, coloring agents, and gum base, for which it was a domestic pioneer. The company also develops and produces active pharmaceutical ingredients (APIs), with specialized capabilities for high-potency compounds, as well as functional food materials and cosmetic and botanical extracts for a global and domestic customer base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 83.3 KB
2025-08-13 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 749.3 KB
2025-08-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.6 KB
2025-05-13 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 757.2 KB
2025-04-28 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.6 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 19.2 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 11.5 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 949.2 KB
2025-03-18 00:00
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 20.6 KB
2025-03-18 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 213.3 KB
2025-03-14 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.3 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 128.2 KB
2025-03-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 12.4 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.1 KB
2024-12-09 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 3.9 KB

Automate Your Workflow. Get a real-time feed of all BOLAK CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BOLAK CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BOLAK CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Celltrion Pharm Inc. Logo
South Korea
068760
Develops bone grafts, artificial joints, and enzymes for the biopharmaceutical sector.
South Korea
049180
Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland
CLN
Celularity Inc Logo
Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.
United States of America
CELU
Centessa Pharmaceuticals plc Logo
Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.
United States of America
CNTA
Century Therapeutics, Inc. Logo
Developing iPSC-derived, off-the-shelf cell therapies for cancer & autoimmune diseases.
United States of America
IPSC
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden
CRNO
CERO THERAPEUTICS HOLDINGS, INC. Logo
Develops engineered T-cell immunotherapies for cancer using its proprietary CER platform.
United States of America
CERO
CERUS CORP Logo
Develops pathogen reduction technology to safeguard the global blood supply for healthcare providers.
United States of America
CERS
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark
CESSA

Talk to a Data Expert

Have a question? We'll get back to you promptly.